AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
UCB S.A.
Video analysis: UCBJY
All videosNo video analysis for this stock yet. Request one from our team.
News: UCBJY
Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers
Trump's MFN push expands to nine mid-sized drugmakers, bringing 26 companies under agreements covering 89% of the branded drug market.
UCB (OTCMKTS:UCBJY) Stock Crosses Below Two Hundred Day Moving Average – Should You Sell?
Shares of UCB SA (OTCMKTS:UCBJY - Get Free Report) passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $145.86 and traded as low as $122.54. UCB shares last traded at $122.60, with a volume of 26,717 shares. Analyst Ratings Changes A number of analysts have
UCB SA (UCBJY) Q2 2026 Earnings Call Transcript
UCB SA (UCBJY) Q2 2026 Earnings Call Transcript
UCB SA (OTCMKTS:UCBJY) Short Interest Down 60.4% in July
UCB SA (OTCMKTS:UCBJY - Get Free Report) was the target of a significant drop in short interest in the month of July. As of July 15th, there was short interest totaling 2,283 shares, a drop of 60.4% from the June 30th total of 5,769 shares. Currently, 0.0% of the company's stock are sold short. Based